Search results
Analysts revise CVS stock targets after Aetna Medicare Advantage earnings plunge
TheStreet.com· 2 hours agoHealth shares. "We have a track record of successfully navigating complex industry pressure, and we’ll continue to demonstrate our resilience," the president and CEO of CVS Health told analysts ...
CVS plummets as rising medical costs hit profit forecast
Crain s Chicago Business· 9 hours agoCompanies including Humana Inc. and UnitedHealth Group Inc. that sell Medicare Advantage plans — private versions of the US government health program for seniors — have warned ...
Maryland's retirees fear mounting healthcare costs due to prescription drug plan changes
WBFF Fox45 Baltimore· 1 day agoLike many retirees, their medicine cabinet is full, with each pill bottle containing a different...
Care N’ Care Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 3 days agoCare N' Care Medicare Advantage plans are available in Texas and get below-average star ratings from...
Caring for older Americans’ teeth and gums is essential but Medicare generally doesn’t cover it
Ohio Capital Journal via Yahoo News· 17 hours agoEverett Koop, the avuncular doctor with a fluffy white beard who served as the U.S. surgeon general...
Does Medicare pay for hearing aids?
CBS News· 6 days agoThe average cost of hearing aids was around $4,600 as of 2018, but these days a pair of prescription-grade hearing aids can cost anywhere from $1,000 to...
What is the Medicare Donut Hole and What Are Your Options?
Penny Hoarder via AOL· 5 days agoMedicare can feel complicated. It’s easy to get overwhelmed when sorting through pages of...
CVS stock plunges after earnings numbers one analyst 'did not even believe'
Yahoo Finance via AOL· 1 day agoFor years, Medicare Advantage (MA) saw increased interest from insurers — the appeal stemming from...
Cost and Brukinsa: Financial assistance options, savings, more
Medical News Today· 2 days agoGet the facts on cost and Brukinsa, how generics compare with brand names, what financial assistance...
Wave of Amicus Briefs Back Drug Price Plan at Trial Court Stage
Bloomberg Law· 7 days agoThe Biden administration’s efforts to fend off legal challenges from the pharmaceutical industry battling Medicare drug price negotiations has drawn reinforcements from officials and academics defending the program.